Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jun 20, 2025
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Award
Common Stock
2025-06-18+6,250→ 54,205 total
Footnotes (1)
- [F1]This restricted stock unit was granted on June 18, 2025. The restricted stock unit will vest over a two-year period. Specifically, 50% of the restricted unit will vest on each of the one-year and two-year anniversaries of the grant date, contingent upon continued service.